Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ⅱ Clinical Study to Evaluate the Efficacy and Safety of CMS-D001 in Adult Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
A Phase 2 multicenter randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of CMS-D001 in adults with modera…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234 [Phase 1]
Phase 1a/1b dose-escalation study of ARQ-234 in adults with atopic dermatitis and eczema is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease [Phase 1]
Phase 1 study of S-4321 in autoimmune and immune-mediated diseases; the trial status is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD [Phase 2]
A Phase 2 clinical trial evaluating Soquelitinib for moderate-to-severe Atopic Dermatitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy
A completed post-authorization safety study in North America evaluating pregnancy and infant outcomes after dupilumab exposure during pregna…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact
A clinical trial update shows a study evaluating tralokinumab for moderate-to-severe atopic dermatitis with genital involvement is currently…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Randomized, Blinded, Placebo-Controlled Evaluation of BioAmicus Complete [NA]
This document is a clinical trial registration for BioAmicus Complete, a randomized, blinded, placebo-controlled study sponsored by NovoNatu…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Bodewell Products for the Treatment of Atopic Dermatitis [Phase 4]
Phase 4 clinical trial update for Bodewell Products in Atopic Dermatitis; the study led by the University of Alabama at Birmingham is curren…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic Dermatitis [Phase 4]
A Phase 4 trial is comparing the safety and effectiveness of Crisaborole Ointment 2% versus Tacrolimus Ointment 0.1% for topical treatment o…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Phase 1a/1b Study of TRB-061 in Healthy Participants & Atopic Dermatitis Patients [Phase 1]
Phase 1a/1b study of TRB-061 in healthy participants and adults with moderate-to-severe atopic dermatitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Seal, Stopping Eczema and Allergy Study [Phase 2]
Phase 2 eczema and allergy trial is being stopped. The current status is ACTIVE_NOT_RECRUITING, indicating no recruitment at this time.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain
A pediatric study of dupilumab for atopic dermatitis in Spain is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Cross-Sectional Study for an Ocular Imaging-Based Predictive Model of Inflammatory Skin Diseases Grounded in Traditional Chinese Medicine
A clinical trial is planned to develop an ocular imaging-based predictive model of inflammatory skin diseases rooted in Traditional Chinese …
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Flourish: Exploring the Early Infant Gut Microbiome [NA]
This clinical trial update describes Flourish, an early infant gut microbiome study sponsored by Seeding Inc, currently recruiting and exami…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema [Phase 2]
Pfizer is conducting a Phase 2 clinical trial to study PF-08049820 in people with atopic dermatitis (eczema); the study is currently active …
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases [NA]
This ClinicalTrials.gov update describes an ongoing study examining how environmental exposure to heavy metals, nanoparticles, and other con…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis [Phase 2]
This Phase 2 clinical trial evaluates the effectiveness and safety of treatments, alone or in combination, for moderate to severe atopic der…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis [Phase 4]
A Phase 4 study evaluating longitudinal endotyping of atopic dermatitis through transcriptomic analysis of skin has completed.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Systems Biology of Early Atopy
NIAID reports an ongoing clinical trial examining the systems biology of early atopy, focusing on allergic diseases and food allergy; the st…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis [Phase 2]
This is a Phase 2 study to evaluate the efficacy and safety of IMG-007 in adults with moderate-to-severe atopic dermatitis, currently recrui…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Preventive Effect of a Dietary Supplement With Two Probiotic Limosilactobacillus Reuteri Strains on Excessive Crying and Colic in Healthy Newborns. [NA]
ClinicalTrials.gov reports recruitment for a dietary supplement study using two Limosilactobacillus reuteri probiotic strains to prevent exc…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
A Phase 2 proof-of-concept clinical trial evaluating IBI3002 in moderate-to-severe Atopic dermatitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis [Phase 2]
This clinical trial is evaluating two Pfizer investigational medicines (PF-07275315 and PF-07264660) for moderate to severe atopic dermatiti…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis [Phase 3]
This is a Phase 3 clinical trial update for ADSTEM Injection to treat moderate to severe subacute and chronic atopic dermatitis; the study i…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years With Atopic Dermatitis
A real-world effectiveness study evaluating long-term dupilumab use in participants aged 6 years and older with atopic dermatitis is current…